Google Joins AbbVie in $1.5 Billion Aging Disease Effort

AbbVie Inc., the drugmaker spun off from Abbott Laboratories last year, and Google Inc.’s Calico will spend as much as $1.5 billion to tackle age-related diseases, including cancer and neurodegenerative disorders.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.